×
About 3,805 results

ALLMedicine™ Neuromyelitis Optica Center

Research & Reviews  1,421 results

Neuromyelitis optica spectrum disorder with active replication of hepatitis B virus and...
https://doi.org/10.1097/MD.0000000000027207
Medicine Lei J, Wang H

Sep 25th, 2021 - Neuromyelitis optica spectrum disorder (NMOSD) associated with active replication of hepatitis B virus (HBV) is rare. High-dose corticosteroids are the mainstay treatment of NMOSD; however, these may cause reactivation of viral replication in pati...

Retinal optical coherence tomography and magnetic resonance imaging in neuromyelitis op...
https://doi.org/10.1080/14737175.2021.1982697
Expert Review of Neurotherapeutics; Lin TY, Chien C et. al.

Sep 24th, 2021 - Neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein IgG antibody associated disorders (MOGAD) comprise two groups of rare neuroinflammatory diseases that cause attack-related damage to the central nervous system...

Evidence for and against subclinical disease activity and progressive disease in MOG an...
https://doi.org/10.1016/j.jneuroim.2021.577702
Journal of Neuroimmunology; Molazadeh N, Filippatou AG et. al.

Sep 22nd, 2021 - Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) and aquaporin-4 IgG seropositive neuromyelitis optica spectrum disorder (AQP4-IgG+ NMOSD) are generally considered to be relapsing disorders, without clinical progression or subclinical ...

Neuromyelitis optica spectrum disorder (NMOSD) associated with cancer: A systematic rev...
https://doi.org/10.1016/j.msard.2021.103227
Multiple Sclerosis and Related Disorders; Shahmohammadi S, Doosti R et. al.

Sep 19th, 2021 - NMOSD: is a disease shown to be highly associated with other diseases such as autoimmune diseases. There are a few reports of this association with cancer. So, this systematic review aimed to obtain a broad understanding on the cancers associated ...

Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444436
Journal of Neuroinflammation; Carnero Contentti E, Correale J

Sep 18th, 2021 - Neuromyelitis optica (NMO) is a chronic inflammatory autoimmune disease of the central nervous system (CNS) characterized by acute optic neuritis (ON) and transverse myelitis (TM). NMO is caused by a pathogenic serum IgG antibody against the water...

see more →

Guidelines  1 results

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515040
Neurology Wingerchuk DM, Banwell B et. al.

Jun 21st, 2015 - Neuromyelitis optica (NMO) is an inflammatory CNS syndrome distinct from multiple sclerosis (MS) that is associated with serum aquaporin-4 immunoglobulin G antibodies (AQP4-IgG). Prior NMO diagnostic criteria required optic nerve and spinal cord i...

see more →

Drugs  3 results see all →

News  96 results

Common MS Treatment Wears Off More Quickly in Black Patients
https://www.medscape.com/viewarticle/949488

Apr 17th, 2021 - Black patients with multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) may respond differently to common MS treatment compared to their White peers, new research suggests. In a study of almost 200 patients, Black participant...

Newly Approved Drugs Offer New Hope in NMOSD
https://www.medscape.com/viewarticle/947267

Mar 11th, 2021 - While they're extraordinarily expensive, a trio of newly approved medications is providing a variety of effective treatment options for patients with neuromyelitis optica spectrum disorder (NMOSD), a neurologist told colleagues. "Patients have a c...

Anti-CD20s Linked to Higher COVID-19 Severity in MS
https://www.medscape.com/viewarticle/946989

Mar 5th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Like other people, patients with multiple sclerosis (MS) who become infected with COVID-19 face worse outcomes if they're older and more disabled,...

FDA Approvals, Highlights, and Summaries: Ophthalmology 
https://reference.medscape.com/viewarticle/945191

Feb 24th, 2021 - Enspryng (satralizumab) Satralizumab is indicated for neuromyelitis optica spectrum disorder (NMOSD) in adults who are antiaquaporin-4 (AQP4) antibody positive. It is a humanized monoclonal antibody that targets the interleukin 6 (IL-6) receptor. ...

New Developments, Challenges in Treating NMOSD
https://www.medscape.com/viewarticle/939569

Oct 22nd, 2020 - New developments in treatment of neuromyelitis optica spectrum disorder (NMOSD) have opened up options for disease treatment in pediatric patients, but have led to some uncertainty and confusion as well. At the2020 CNS-ICNA Conjoint Meeting, held ...

see more →

Patient Education  1 results see all →